- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06656871
Biostimulants Application to Lettuce (SwE4WEEKS)
Biostimulants Application to Vegetables
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present project aims to investigate the benefits of biostimulants lettuce in a cohort of healthy individuals. Biostimulants are organic and inorganic compounds or microorganisms that when applied to plants can enhance plants' growth, yield, and tolerance to stress. Seaweed extract treatment seems to enhance mineral concentration in crops. Participants will be fed with biostimulated lettuce or a tablet of iron daily in order to study the influence on hematological parameters.
A cohort of healthy subjects will be divided into a control group, receiving control lettuce, lettuce SwE group, receiving biostimulated lettuce and iron tablet group receiving iron bisglycinate (30 mg) supplement in tablet for a total of 4 weeks. Blood samples will be collected in specific tubes before (baseline) and after the nutritional intervention (T2). The group will eat 100 grams of Lettuce (control group) and 100 grams of SwE Biostimulated lettuce (intervention group lettuce) for 4 weeks (100 grams/daily) or a tablet of iron (intervention group iron tablet) and collect blood samples (serum and plasma) baseline, before starting the nutritional intervention and after 4 weeks (T2).
Each subject will be subjected to two venous blood samples taken at the beginning of the observation and at the end. The samples obtained will be transported in certified containers for the safe transport of biological samples, and, subsequently, processed by the experimenters at the laboratories of the Molecular Biology section of the University of Palermo. Serum and plasma will be obtained from each blood sample. All information thus obtained will be recorded in a database in which each person will be identified with a numerical code, in order to comply with current privacy regulations. Body weight, Barefoot standing height, Body mass index, Body composition will be measured in the different groups of study. Samples will be analyzed and compared for glucose, insulin, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Ferritin, Iron, transferrin, Magnesium, Calcium, Potassium, Phosphate, Potassium.
Statistical analysis plan:
Student t tests will be used to compare the baseline characteristics of the groups. Changes between baseline and follow-up will be analyzed by one-way ANOVA followed by Sidak post test. A P < 0.05 will be considered to be statistically significant by using appropriate software.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Palermo, Italy, 90128
- NABbio, STEBICEF department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 20 - 70 years
- Italian Ethnicity
- Body mass index between 18.5 and 28.5 kg/m2
- Clinically Healthy
Exclusion Criteria:
- Chronic disease
- Use of drugs
- Pregnancy
- Exogenous hormones
- Breastfeeding
- Use of supplements
- sensitivity to lettuce
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group received lettuce (control lettuce 100 grams/day) that was without any biostimulation with Ecklonia Maxima algae but with the same characteristic of SwE lettuce (soil, water, harvesting time) for 4 weeks.
|
|
|
Experimental: Biostimulated SwE lettuce intervention group
The SwE lettuce intervention group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) for 4 weeks
|
the intervention group SwE lettuce group received lettuce biostimulated with Ecklonia Maxima algae (SwE lettuce, 100 grams/day) daily for 4 weeks
|
|
Experimental: Iron tablet intervention group
The iron tablet intervention group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks
|
The iron tablet group received iron supplementation (30 mg, 1 tablet/day of iron) for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of minerals concentration in participants
Time Frame: 4 weeks
|
Calcium (mg/dL), Phosphate (mg/dL), Magnesium (mg/dL) will be assessed in serum at baseline and after 4 weeks.
|
4 weeks
|
|
Measurement of iron concentration in participants
Time Frame: 4 weeks
|
Iron (μg/dL) will be assessed in serum at baseline and after 4 weeks.
|
4 weeks
|
|
Measurement of Potassium concentration in participants
Time Frame: 4 weeks
|
Potassium (mmol/L) will be assessed in serum at baseline and after 4 weeks.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of ferritin in participants
Time Frame: 4 weeks
|
Ferritin (ng/dL) will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of lipid metabolism markers in participants
Time Frame: 4 weeks
|
triglicerises, HDL, LDL, cholesterol (in mg/dL) will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of insulin in participants
Time Frame: 4 weeks
|
insulin (mUI/L) will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of transferrin in participants
Time Frame: 4 weeks
|
transferrin (mg/dL) will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of % saturation of transferrin in participants
Time Frame: 4 weeks
|
% saturation of transferrin will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of glucose in participants
Time Frame: 4 weeks
|
glucose (mg/dL) will be measured in serum at baseline and after 4 weeks
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of Height in participants
Time Frame: 4 weeks
|
Height (meters) will be assessed at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of body mass index (BMI) in participants
Time Frame: 4 weeks
|
weight in kilograms, height in meters will be aggregated to arrive at one reported value (weight and height will becombined to report BMI in kg/m^2).
|
4 weeks
|
|
Measurement of body weight in participants
Time Frame: 4 weeks
|
Body weight (kg) will be assessed at baseline and after 4 weeks
|
4 weeks
|
|
Measurement of body composition in participants
Time Frame: 4 weeks
|
lean mass as percent of body weight and fat mass as percent of body weight will be assessed at baseline and after 4 weeks
|
4 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- ttps://www.mdpi.com/2073-4395/12/6/1361 Description: Plant-Derived Biostimulants Differentially Modulate Primary and Secondary Metabolites and Improvethe Yield Potential of Red and Green Lettuce Cultivars
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SwE4WEEKS23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
RenJi HospitalGuangdong Provincial People's Hospital; Shanghai First Maternity and Infant... and other collaboratorsEnrolling by invitationPCOS | IVF Outcome | Glucose Metabolism DisorderChina
-
University of PlymouthRecruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
Wake Forest University Health SciencesNot yet recruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United States
Clinical Trials on Biostimulated lettuce supplementation
-
University of PalermoCompletedHealthy IndividualsItaly
-
Newcastle UniversityCompletedBlood Pressure | Dietary ModificationUnited Kingdom
-
Wuerzburg University HospitalCompleted
-
Pusan National University Yangsan HospitalActive, not recruitingMild Cognitive Impairment (MCI)South Korea
-
University of PalermoCompleted
-
University of PalermoCompletedGlucose Metabolism Disorders | Bone Resorption | Hepatic Steatosis | Nutrition, Healthy | Dietary Deficiency | Lipid Metabolism DisorderItaly
-
University of NottinghamCompletedAsymptomatic ConditionsUnited Kingdom
-
University of PalermoCompleted
-
University College, LondonRecruiting
-
University of ThessalyCompletedPostbiotics SupplementGreece